Current location - Trademark Inquiry Complete Network - Trademark inquiry - Australia announced the recognition of Kexing vaccine. What does this mean for China COVID-19 vaccine?
Australia announced the recognition of Kexing vaccine. What does this mean for China COVID-19 vaccine?
Australia announced the approval of Kexing vaccine, which means that the domestic vaccine has been recognized by all walks of life in the world, and with the protection of domestic epidemic situation and vaccine protection, it should have been recognized long ago.

Everyone can see the effect and protective power of China vaccine, but out of prejudice against China, Australia recognized the protective efficiency of Kexing vaccine very late.

CoronaVac is a novel coronavirus vaccine developed by Beijing Kexing Zhongwei Biotechnology Co., Ltd..

On February 5th, 20021,the State Administration of Pharmaceutical Products approved the conditional listing of inactivated vaccine Kelaifu from novel coronavirus in China. On June 1, the World Health Organization announced that Clive had officially passed the WHO emergency use certification.

Novel coronavirus, abbreviated as "COVID-19", was named "20 19 coronavirus disease" by the World Health Organization, which refers to pneumonia caused by novel coronavirus infection in 20 19. Since 20 19 and 12, many cases of unexplained pneumonia with a history of exposure to the seafood market in South China have been found in some hospitals in Wuhan, Hubei Province, and were diagnosed as acute respiratory infectious diseases caused by novel coronavirus infection in 20 19.